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NKCC1 and NKCC2 187Naþ ,Kþ, 2Cl cotransporters (NKCC) encoding by SLC12A2Table 2 Effect of ouabain and bumetanide on the volume
of human lung fibroblasts.
Additions Cell volume, pl per cell
None (control) 0.23  0.04
Ouabain 0.26  0.04
Bumetanide 0.22  0.01
Ouabain þ bumetanide 0.43  0.04*
Cells were incubated in the presence of 0.1 mM ouabain and/(NKCC1) and SLC12A1 (NKCC2) belong to the subfamily of
cation-chloride cotransporters (CCCs) that provide elec-
troneutral transport of sodium, potassium and chloride
across the plasma membrane and are inhibited by bume-
tanide, furosemide and several other structurally similar
compounds (Table 1). Because the major target of these
drugs is inhibition of ion transport in thick ascending limb of
Henle’s loop (TAHL), they were termed as high-ceiling di-
uretics. Gene structure, membrane architecture and
pharmacology of SSSs were subjected to detailed analysis
in several comprehensive reviews.1e3 This review focuses
on physiological significance of NKCCs and their involve-
ment in the pathogenesis of hypertension via regulation of
intracellular chloride concentration and sensing chloride
concentration in the renal tubular fluid.or 10 mM bumetanide for 24 h. Cell volume was measured as
14C-urea available space.9 Means  S.E. obtained in experi-
ments performed in quadruplicate are shown. *p < 0.005
compared to control.Functional implications of NKCCs
Cell volume regulation
Animal cells maintain their volume with an accuracy of
1%e2% by means of systems providing inwardly and
outwardly directed fluxes of monovalent ions and organic
osmolytes and termed as regulatory volume increase (RVI)
and regulatory volume decrease (RVD), respectively.4,5 In
early studies with mammalian erythrocytes, we and others
have shown that cell shrinkage and swelling result in acti-
vation of NLCC and Kþ, Cl cotransport (KCC),
respectively.6e8 We also demonstrated that in vascular
smooth muscle cells (VSMC) subjected to hyperosmotic
shrinkage, RVI is caused by activation of NLCC.9 It is
noteworsy that under the baseline isosmotic conditions,
inhibition of NKCC by bumetanide does not significantly
affect the volume of human lung fibroblasts (Table 2),
suggesting that in the absence of external stimuli, NLCC
has a minor impact on the generation of net osmolite fluxes
in these cells. However, under inhibition of the Naþ, Kþ-
ATPase by ouabain, treatment with bumetanide resulted in
w2-fold elevation in the volume of human lung fibroblasts
(Table 2). This observation suggests that dissipation of
transmembrane gradient of monovalent cations evoked byTable 1 Major characteristics of Cl-coupled cation cotranspor
Gene Human chromosome localization Protein Alterna
SLC12A2 5 NKCC1 NA
SLC12A1 15 NKCC2 Isoform
SLC12A3 16 NCC NA
SLC12A4 16 KCC1 NA
SLC12A5 20 KCC2 NA
SLC12A6 15 KCC3 Isoform
SLC12A7 3 KCC4 NA
NA, information not available.Naþ, Kþ-ATPase inhibition results in generation of inwardly-
directed ion flux mediated by NLCS1, the only isoform of
NLCS expressed in these cells. Functional consequences of
the disturbances of cell volume regulatory machinery are
discussed elsewhere.4,10,11NKCC as a regulator of intracellular ClL
concentration
In all types of cells studied so far, SSSs generate both
inwardly and outwardly-directed ion movements and the
direction of net flux depends on carrier’s stoichiometry and
transmembrane gradients of sations created by Naþ, Kþ-
ATPase. Thus, the stoichiometry 1:1 predicts that the
value of ion flux is in direct proportion to concentration of
co-transporting ions. Because [Naþ]o>>[Na
þ]i,
[Kþ]i>>[K
þ]p and [Sl
]o>[Cl
]i, net fluxes generated by
Naþ, Clcotransport (NCC) and KCC exhibit inward and
outward directions, respectively. In the majority of cells
[Sl]o
2>>>[Cl]i
2, and net flux mediated by electroneutral
NKCC functioning with the stoichiometry 1Naþ:1Kþ:2Cl
has inward direction.
The above consideration suggests that SSSs play a key
role in the regulation of [Cl]i whereas their contribution to
the adjustment of intracellular concentration of mono-
valent cations is negligible because of the highly active
Naþ, Kþ-pump. Indeed, it was shown that inhibition of NCCtes.1,3
tive spicing Tissue localization Inhibitors, IC50 (mM)
Ubiquitous Bumetanide, 0.05e0.60
Furosemide, 10e50
s A, B and F Kidney Bumetanide, 0.10e0.50
Furosemide 15e60
Kidney Polythiazide, 0.5
Ubiquitous Bumetanide, 60
Neurones Bumetanide, 55
Furosemide, 10
s A and A Neurones Bumetanide, 40
Furosemide, 25
Ubiquitous Bumetanide, 900
Furosemide, 900
188 S.N. Orlov et al.and NLCC results in attenuation of [Cl]i whereas sup-
pression of LSS activity increases this parameter.12
Importantly, the alteration of CCC activity may lead to
adjustment of [Cl]i above or below the values corre-
sponding to Nernst’s equilibrium potential. This means that
in cells abundant with anion channels, SSSs contribute to
maintenance of electrical potential thus having an impact
on the whole spectrum of cellular functions controlled by
potential-sensitive proteins localized within the plasma
membrane. This conclusion is supported by data discussed
in the next sections.
VSMC contraction
In skeletal and cardiac muscle, plasma membrane perme-
ability for Lþ (PK) plays a major role in the maintenance of
electrical resistance and resting potential (Em). In contrast,
the values of PK and PCl in smooth muscles are about the
same,13 suggesting that in VSMC CCCs may be involved in
regulation of the [Cl]i/[Cl
]o ratio and therefore of Em and
excitation-contraction coupling. Indeed, NKCC inhibition by
furosemide or bumetanide resulted in a decreased
[Cl]i
14,15 and led to hyperpolarization of rat VSMC.14 These
data suggest that decreased baseline tone seen in smooth
muscles treated with Henle’s loop diuretics,16e18 as well as
attenuation by these compounds of contraction of smooth
muscle strips evoked by modest increment of [Kþ]o,
15 by
electrical stimulation,19 by histamine,20 angiotensin II,21
thrombaxane A2,
22,23 oxitocyn,24,25 a-adrenergic15,26,27,28
or purinergic29 agonists is caused by Cli -dependent hyper-
polarization and suppression of the activity of voltage-
gated L-type Ca2þ channels.
Myogenic response
Myogenic tone (response) is a unique property of small
(<100e200 mm) blood vessels to decrease rather than in-
crease their inner diameter in response to elevated intra-
luminal pressure. Both kinetic and the amplitude of
myogenic response are different in blood vessels of different
origins. Importantly, myogenic response in blood vessels
from the brain, skeletal muscle and renal afferent arteriole
provides constant blood supply of these tissues indepen-
dently of the changes in the systemic blood pressure.30e32
It was reported that bumetanide decreased the
myogenic tone of mesenteric arteries33 and completely
abolished myogenic response of renal afferent arteriole.23
We demonstrated that inhibitory action of bumetanide
(but not of L-type Sa2þ channel blocker nicardipine) on the
myogenic response as well as on contraction triggered by a-
adrenergic stimulation is absent in mesenteric arteries from
NKCC1/ mice.33 Because NKCC2 is not expressed in SMC,
these data suffest that bumetanide and other loop’s di-
uretics inhibit contraction and myogenic response of
vascular SMC via their interaction with NKCC1, i.e., an
ubiquitous isoform Naþ, Kþ, 2Cl cotransporter.
Synaptic transmission
Neuroneneuron interactions are controlled by neurotrans-
mitters via regulation of transduction of electrical signals.Excitatory and inhibitory neurotransmitters lead to depo-
larization and hyperpolarization of postsynaptic mem-
brane, respectively. For example, ionotropic glutamate
receptor and acetylcholine receptors cause depolarization
of postsynaptic membrane via increment of ion current
mediated by ion channels permeable for Naþ and Ca2þ. In
contrast, hyperpolarization results from the increment of
the permeability of Kþ channels triggered by activation of
metabotropic acetylcholine receptors. Unlike above-listed
neurotransmitters, gamma-aminobutiric acid (GABA) in-
creases permeability for Cl and other low molecular
weight anions via its interaction with ionotropic GABAA re-
ceptors. Direction of net flux mediated by these receptors
is determined by transmembrane chloride gradient and
electrical potential of postsynaptic membrane. In case RT/
F  ln([Cl]o/[Cl]i)<Em, the net chloride flux will be
directed into the cells which will lead to hyperpolarization
and attenuation of neuronal activity. An elevation of [Cl]i
changes the direction of net chloride flux and in this case
activation of GABAA receptors leads to elevation of
neuronal activity.
Keeping this in mind, one may assume that the ratio of
activity of NKCC1 and LSS2, providing inwardly and
outwardly directed Cl fluxes in neuronal cells, respec-
tively, plays a key role in the function of GABAA receptors.
Indeed, the attenuation of NKCC1 activity on the back-
ground of elevated LSS2 is the major mechanism of the
alteration of the functional properties of GABAA receptors
in central neuronal system (CNS) of mammals during onto-
genesis: GABAA receptors function as activatory receptors
in prenatal stage but became inhibitory ones few days after
birth (for review see34e36).Salt reabsorption by NKCC2
A major impact of NKCC in salt reabsorption and regulation
of extracellular fluid volume (EFV) is well-established by
the clinical use of furosemide and other inhibitors of these
carriers as potent diuretics,37 as well as by salt-lasting
characteristic of the loss-off-function mutations of NKCC2
that underpin type I Barter syndrome.38 Importantly, in
addition to salt reabsorption in the TAHL, NKCC2 contrib-
utes to the regulation of salt excretion via tubuloglomerular
feedback (TGF) in the juxtaglomerular apparatus (JGA)
neighbouring to the distal segment of TAHL and consisting
of epithelial cells of macula densa (MD), mesangial cells
and VSMC. Such location is unique along the nephron and
plays a key role in the JGA function. Indeed, [NaCl] in renal
fluid delivered to the MD is in the range of 20e60 mM. This
is in sharp contrast to the proximal tubule, where concen-
trations of most solutes deviate modestly from those in
plasma (for more details, see 39e41). TGF is triggered
immediately after elevation of salt concentration in the
tubular fluid delivered to the JGA and results in the
contraction of VSMC of afferent arterioles, thus causing
increases in the exposure of proximal tubules to high-salt
fluid via the attenuation of glomerular capillary pressure
and the glomerular filtration rate (GFR). As a consequence
of this negative feedback loop, salt delivery to the distal
nephron is kept within a narrow range. This process facili-
tates the fine adjustment of salt handling in the distal
NKCC1 and NKCC2 189tubules by corticosteroids and peptide hormones, such as
aldosterone and arginine vasopressin (AVP).42,43
Similar to TAHL, the apical membrane of the MD cells is
abundant in NKCC2, which provides up to 80% of apical NaCl
entry in these cells.44e46 Early studies of Wilcox and co-
workers demonstrated that changes in the plasma [NaCl]
affect renal blood flow in dogs mainly via modulation of
plasma chloride concentration.47,48 It was also shown that
regulation of renal blood flow is mediated by activation of
[Cl]o-sensitive, osmolality-independent TGF.
49e51 Because
of its stoichiometry (1Naþ:1Kþ:2Cl), the [Cl]o sensing by
NKCC2 has an advantage compared to monovalent cations.
Indeed, unlike MichaeleMenten’s pattern for Naþ and Kþ
dependencies, binding of Cl to NKCC is a cooperative
process with a Hill coefficient of 2,52 providing high-
efficiency regulation of carrier activity in the range of
[Cl]o existing in the JGA and close to the EC50 value of the
transporter.
Using isolated rabbit cortical TAHL with attached
glomeruli, Laamerti and co-workers determined that NKCC
in MD cells was activated by Naþo and Cl

o with the EC50 of
1.0 and 17 mM, respectively.45 Importantly, three
alternatively-spliced NKCC2 isoforms (A, B and F) cloned
from rabbit53 and mouse54 cDNA libraries. These splice
variants, are differently distributed along the nephron: the
NKCC2B and the NKCC2A are co-expressed in the MD,
whereas the NKCC2F is prevalent in the medullary
TAHL.55e57 In Xenopus oocytes, the EC50 values of mouse
NKCC2B for Kþo , Na
þ
o and Cl

o are 0.8, 3.0 and 12 mM,
respectively.58 Very similar EC50 values for Na
þ and Cl
were obtained in a study of the rabbit NKCC2B.59 In Xen-
opus oocytes injected with NKCC2A, the EC50 values for Na
þ
are very close to the those for NKCC2B, whereas the affinity
for Cl is 2e5 folds lower.58,59 It was also shown that the
NKCC2F-transfected oocytes are more energy-efficient in
Naþ uptake thus indicating a key role of this splice-variant
in overall salt reabsorption in TAHL.60 Indeed, experiments
performed in gene knock-out animals demonstrated that
NKCC2B and NKCC2A contribute to salt absorption and MD
function in the low and high NaCl concentration ranges,
respectively.61,62 Importantly, the range of NKCC activation
by Clo was consistent with the range of modulation of TGF
and renin production by the apical NaCl and was similar to
the Cl concentration in tubular fluid delivered to rat distal
tubules.63 Downstream signaling events triggered by acute
changes in apical [Cl] were discussed in several compre-
hensive reviews.2,44,64Salt secretion by NKCC1
Unlike apical location of NKCC2 in the absorptive epithelia,
NKCC1 was found in the basolateral membrane of the
secretory epithelia.65 Several laboratories including our
team reported that activity of NKCC is decreased by 2e3
folds in erythrocytes from Blacks compared to
Caucasians.66e70 Keeping in mind that NKCC1 is the only
isoforms expressed in erythrocytes, we proposed that
attenuated activity of this carrier evokes salt retention
seen in African-Americans via its manifestation in the
basolateral membrane of sweat glands.71 Several observa-
tions favour this hypothesis. First, both bumetanide-sensitive 86Rb uptake and chloride fluxes across secretory
epithelium are suppressed in NKCC1/ knock-out mice.72
Second, in humans, sweat glands contribute to up to 50%
of total salt and water excretion during extensive exercise
and psychoemotional activity.73 Third, in a hot environ-
ment, the function of sweat glands as a potent regulator of
EFV is suppressed in Blacks compared to Caucasians.74
Fourth, salt retention by sweat glands results in
augmented salt loading of renal distal tubule, which, in
turn, leads to apical membrane depolarization and
enhanced Kþ secretion.75 The latter is consistent with more
than a 5-fold prevalence of unprovoked hypokalemia
detected in African-Americans compared to Caucasians.76
In contrast to human, sweat glands have a negligible
impact on EFV regulation in rodents and other small mam-
mals.77 Because of this, NKCC1/ knockout mice possess-
ing slightly attenuated blood pressure than wild-type
animals72 cannot be used to examine the sweat gland-
mediated mechanism of NKCC1 involvement in salt
handling and hypertension. Keeping this comment in mind,
the comparative analysis of Naþ,Kþ,2Cl cotransport and
transcellular ion transport in secretory epithelial cells from
Blacks and Whites is probably the best approach to examine
the relative impact of NKCC1 in blood pressure regulation
via its implication in the EFV adjustment.
Role of NKCC in the pathogenesis of hypertension
Elevation of systemic blood pressure has been documented
in 25% of adults and is a major risk factor for stroke, heart
failure, renal disease resulting in premature invalidization
and death.78 A priori, elevation of the systemic blood
pressure may be a consequence of the increase of periph-
eral resistance of blood flow, heart rate and EFV. In turn,
above-listed parameters are under the control of dozen of
hormones, neurotransmitters and sympathetic nerve sys-
tem (SNS) affecting heart, blood vessels and renal func-
tion.79 In several forms of systematic hypertension,
servomechanisms underlying long-term elevation of blood
pressure are well-documented. This is the case of hyper-
tension caused by adrenal tumors and renal insufficiency as
well as by a set of single gene mutations in monogenous
hypertension and hypotension. These forms of disease
found in less than 5% of patients with elevated blood
pressure are combined by common name of a secondary
hypertension. In the rest of patients with primary or
essential hypertension, the mechanisms of blood pressure
elevation remain poorly understood.
Monogenous forms of secondary hypertension and
hypotension
Monogenous forms of hypertension and hypotension iden-
tified so far are caused by mutations of genes involved in
regulation of EFV by renal epithelial cells.80,81 This is
consistent with a key role of the kidney in long-term
maintenance of elevated blood pressure as described by
Artur Guyton.82 Among monogenous forms of hypertension
and hypotension, three types of mutations result in altered
function of SSSs. The loss-off-function mutations of
NKCC2 and NCC detected in patients with Barter type I and
190 S.N. Orlov et al.Gitelman syndrome, respectively, lead to attenuated salt
reabsorption in thick ascending limb of Henle’s loop and
distal nephron, which, in turn, results in a decreased EFV
and systemic blood pressure.38,83 In both diseases inherited
in accordance with classic Mendel’s genetics, hypotension
is accompanied by hypokalemia and alkaloidosis e universal
markers of decreased reabsorption of salt in distal nephron.
In contrast, in patients with pseudohypoaldosteronism type
II (ROAII) also known as Gordon’s syndrome, hypertension
is caused by mutations in with-no-K(lysine) kinases WNK1
and WNK4 resulting in activation of NCC, increased sodium
reabsorption and hyperkalemia.84Primary hypertension
Unlike monogenous forms of secondary hypertension,
elevation of blood pressure in primary hypertension is a
consequence of a complex combination of inheriting traits
and several environmental factors including limited phys-
ical activity, obesity, smoking, the augmented consumption
of salt and alcohol. Inherited traits are probably caused by
altered function of 4e5 genes whose combination may be
different even within the same human population,85
underlining mosaic origin of the pathogenesis of essential
hypertension as noted for the first time by Pickering.86
Up-to-now, there are no reports on mutations of NKCC2
and other renal-specific CCCs in patients with essential
hypertension. Schiebl and co-workers found that in mice
differential splicing of NKCC2 pre-mRNA is modulated by
dietary salt intake,87 which may be triggered by recently
discovered [Naþ]i/[K
þ]i-mediated excitation-transcription
coupling (for review, see88). Enhanced tubular reabsorp-
tion of salt and osmotically-obliged water is important
determinant of obesity-related hypertension. Davies and
co-workers reported that increased activity of NKCC2 in
high-fat diet mice is caused by STE20/SPS1-related proline/
alanine-rich kinase SPAK/OSR1-mediated phosphorylation
of this carrier at serine-126.89 Additional studies should be
performed to examine the role of this signaling pathway in
the regulation of renal-specific CCCs in the pathogenesis of
essential hypertension.
In the early studies, it was shown that elevated perme-
ability for monovalent cations of VSMC90 as well as eryth-
rocytes from spontaneously hypertensive rats (SHR)91 and
patients with essential hypertension92 is at least partially
caused by augmented activity of NKCC (for review,
see.93e97). Because NKCC1 is the only isoform of Naþ,
Kþ,2Cl cotransporters identified in erythrocytes, these
data indicate that at least in these experimental models of
human primary hypertension, augmented activity of this
carrier contributes to activation of servomechanisms for
long-term elevation of systemic blood pressure. This
conclusion can be supported by several observations. First,
in erythrocytes of F1 hybrids obtained by crossing of Milan
hypertensive strain (MHS) and Milan normotensive strain
(MNS) rats and subjected to X-ray irradiation, NKCC activity
was increased after transplantation of bone marrow from
MHS but not from MNS.98 Second, in erythrocytes of F2
MHS  MNS hybrids as well as F2 hybrids obtained by
crossing of SHR and normotensive Wistar-Kyoto (WKY) rats,
NKCC activity positively correlated with bloodpressure.98,99 Third, several researchers demonstrated
decreased blood pressure in NKCC1/ knock out
mice.72,100,101 Fourth, administration of bumetanide, a
potent inhibitor of Naþ, Kþ,2Cl cotransport, decreased
blood pressure in wild-type but not in NKCC1/ mice.27
These findings raise a question on the mechanisms for
the involvement of NKCC1 in the pathogenesis of hyper-
tension. Data considered above suggest that these mecha-
nisms may involve NKCC1-mediated regulation of [Cl]i
which, in turn, affects VSMC contraction and SNS activity.
Indeed, it was shown that inhibitory action of bumetanide
on the contraction of mesenteric arteries evoked by acti-
vation of a-adrenergic receptor is increased in SHR
compared to normotensive controls.102,103 Due to the
methodological problems, data on the activity of NKCC in
freshly isolated VSMC in primary hypertension are limited to
few publications.94,95 It was shown, however, that the
content of NKCC1 mRNA and immunoreactive protein is
increased in aorta and heart from SHR.102 Elevation of
sympathetic tone may lead to elevation of systemic blood
pressure via its impact on cardiovascular system and the
kidney.104e107 This hypothesis is consistent with numerous
reports on activation of SNS in patients with essential hy-
pertension104 and SHR.108
The major role of CNS in activation of paraventricular
nucleus (PVN) in hypothalamus possessing hyperactivity in
primary hypertension is well documented.109e111 It is also
known that presynaptic neurons in PVN are activated by
excitatory glutamatergic neurones and suppressed by
inhibitory GABAergic neurons, respectively.112 Importantly,
activity of GABAergic neurons is decreased in PVN of
SHR.112,113 As mentioned above, the relationship between
the inhibitory and stimulatory actions of GABAA receptors is
determined by intracellular chloride concentration that is
under the control of the ratio of NKCC1 vs. KCC2 activities.
Recent studies demonstrated that the value of the equi-
librium potential for GABAA receptors (FGABA) is shifted to
positive values in PVN of SHR by 15 mV, which corresponds
to a 2-fold elevation of [Cl]i compared to normotensive
control.114 This difference as well as decreased inhibitory
activity of GABAergic neurons in SHR was abolished by
addition of low doses of bumetanide but not furosemide.
These results allowed authors to propose that augmented
[Cl]i in SHR neurons is caused by activation of NKCC1
rather than inhibition of LSS2. This conclusion is in
agreement with elevated of NKCC1 mRNA and immunore-
active protein levels with no changes in LSS2 content in
PVN of SHR.114
Mechanisms of elevation of NKCC1 activity in primary
hypertension remain poorly investigated, which probably
reflects the polygenic and mosaic origin of this disease as
well as diverse mechanisms of regulation of the activity and
expression of CCCs. For example, elevation of [Ca2þ]i ac-
tivates whereas production of cAMP inhibits this carrier in
VSMC.26,115,116 Numerous investigations documented
abnormal activity of both signaling systems in primary hy-
pertension.117,118 Recent studies demonstrated a key role
of WNK, SPAK and OSR1 kinases in regulation of several
CCCs including NKCC1 and NKCC2 (for reviews, see119e122).
Bergaya and co-workers reported that both phosphorylation
of NKCC1 and increment of blood pressure evoked by acti-
vation of a-adrenergic receptors is decreased in Wnkþ/
NKCC1 and NKCC2 191mice.123 Bumetanide-sensitive component of vessel
contraction was also attenuated in SPAK knock-out mice.124
To further examine the role of this signalling pathway,
Rafiqi and co-workers generated knock-in mice in which
SPAK cannot be activated by WNKs. These animals display
reduced salt-dependent increment of blood pressure as
well as decreased expression of NKCC2 and NCC proteins
with no changes in mRNA level.125 It is noteworthy, how-
ever, that there is no evidence for mutations of genes
encoding SSSs or WNK/SPAK/PSR1 regulatory pathway in
primary hypertension in contrast to monogenic
hypertension.
Epigenetic phenomena include DNA methylation, post-
translation histone modification and expression of non-
coding RNAs. Epigenetic mechanisms are under complex
control of diverse environmental factors, which make them
crucial for their involvement in the pathogenesis of hy-
pertension and other complex and multifactorial disor-
ders.126 Recent studies suggest that NKCC1-mediated
abnormalities of ion transport have epigenetic origin.127 It
has been shown that the contents of NKCC1 mRNA and
protein are increased in aorta, heart and PVN neurones
from rats with spontaneous hypertension.102,114 In SHR
aorta and heart, increased expression of NKCC1 is accom-
panied by attenuated methylation of its promoter.102
Importantly, methylation of NLSS1 promoter exhibited
age-dependent increase in normotensive rats but not in
SHR. It was also shown that the activity of DNA methyl-
transferase 3C (DNTB3B) is 3-fold higher in normotensive
rats as compared to age-matched SHR.103 These results
suggest that in this experimental model of primary hyper-
tension, decreased activity of DNTB3B results in hypo-
methylation of NLSS1 promoter, which in turn leads to
augmented NKCC1 expression, increment of [Cl]i, depo-
larization and contraction of SMC, increased vascular
resistance and elevation of blood pressure.
The role of epigenetic factors in augmented expression
of NKCC1 in neurones of PVN of SHR, controlling activity of
SNS, remains unknown. However, it was shown that in PVN
from SHR, NKCC1 is highly glycosylated, which may
contribute to increased content of membrane-bound pro-
tein, i.e., the fraction of the carrier providing Naþ, Kþ,2Cl
cotransport.114 Thus, glycosylation of NKCC could represent
another level of its regulation.Complications caused by elevated blood pressure
The major cause of the premature death of patients with
essential hypertension is a damage of the target organs
such as brain vessels and the kidney due to chronic eleva-
tion of local blood pressure.128 Blood pressure elevation in
the brain microcirculation increases the probability of
nonreversible damage of the blood flow that results in
stroke, whereas in the kidney high blood pressure leads to
structural alterations in the nephron, changes of salt-water
homeostasis and proteinuria.78
Keeping in mind that Rbf w 1/d
4 (where Rbf is the blood
flow resistance and d is the inner vessel’s diameter),129
myogenic response plays a key role in the protection of
target organs from elevation of systemic arterial pressure.
It was shown that chronic suppression of myogenicresponse in patients with essential hypertension as a
consequence of hypertrophy of vessel’s wall leads to
attenuation of its sensitivity to the changes of intraluminal
pressure. As a result of these changes, an increment of
systemic blood pressure is transferred to microcirculation
beds incorporated into the brain, heart, retina, kidney,
which causes irreversible changes in the structure and
function of these and other target-organs of
hypertension.130,131
To investigate the role of myogenic response in the
kidney function, Loutzenhiser and co-workers employed
isolated perfused kidney, which allowed them to study
renal microcirculation in the absence of its modulation by
JGA.132 Using this model, they have shown that bumetanide
completely suppresses myogenic response of afferent
arteriole in the rat kidney.23 Together with the absence of
myogenic response in Nkss1/ mice33, these results may
suggest that augmented activity of NKCC1 in SHR, MHS rats
and in patients with essential hypertension protects kidney
from the damage by prolonged elevation of the systemic
blood pressure whereas chronic administration of furose-
mide and other NKCC inhibitors accelerates the renal
insufficiency and proteinuria.71,96,97 In other words, high
activity of NKCC1 in VSMC of the afferent arteriole main-
tains the constant renal blood flow even after elevation of
systemic blood pressure caused by activation of this carrier
in mesenteric arteries and other vessels contributing to
regulation of peripheral resistance (Fig. 1). This hypothesis
is consistent with 4-fold increase of renal complications in
African-Americans with hypertension possessing up to 3-
fold attenuation of NKCC activity in erythrocytes as
compared to age-matched hypertensive Caucasians.70,71
The relative contribution of Sa2þ channels and NKCC1 in
the myogenic response of coronary and SNS microcircula-
tory beds remains unexplored.
Ischemia is the major consequence of even a brief
disturbance of blood circulation in the brain vessels that
leads to irreversible damage of the neuronal function. It
was shown that attenuation of the oxygen partial pressure
results in astrocyte swelling, which in turn leads to a
release of glutamate and other neurotransmitters trig-
gering massive Ca2þ influx in neurones and their
death.133,134 It was shown that bumetanide suppresses
astrocyte swelling, neurotransmitter’s release135 and the
death of neurones in the hippocampus subjected to hypoxia
and hypoglycemia.136 Moreover, both [Kþ]o-induced
swelling and release of neurotransmitters evoked
by ischemia are sharply decreased in astrocytes from
NKCC1/ mice,137 thus indicating that activation of NKCC1
is a mechanism for astrocyte swelling. We have reported
that elevation of [HCO3
e]o decreases NKCC activity in VSMC
from rat aorta.138 Thus, activation of NKCC1 under hypoxic
conditions might be caused by acidosis-mediated attenua-
tion of [HCO3
] in cerebrospinal fluid. Hypoxia is also
accompanied by sharp attenuation of intracellular ATP
content and inhibition of the Naþ,Kþ-ATPase.139 As shown in
Table 2, inhibition of the Naþ,Kþ-ATPase changes the di-
rection of NKCC1-mediated net ion fluxes and evokes cell
swelling. Additional experiments should be performed for
evaluation of the relative impact of Naþ,Kþ-pump and
NKCC1 in regulation of astrocyte volume in ischemic
conditions.
Figure 1 The scheme showing implication of cation-chloride cotransporters in the pathogenesis of essential hypertension and its
cardiovascular and renal complications. Augmented salt consumption leads to elevation of extracellular fluid volume (EFV) via salt
reabsorption by NKCC2 in the thick ascending limb of Henle’s loop (TAHL), NCC in distal tubule (DT) and sensinig of Cl conceration
in tubular fluid delivered to juxtaglomerular apparatus (JGA) by NKCC2. Augmented activity of NKCC1 in vascular smooth muscle
cells (VSMC) resulted in elevation of peripheral resistance and systemic blood presure (SBP). Augmemted activity of NKCC1 and
attenuated of KCC2 in neuronal cells of paraventricular nucleus (PVN) also contributes to SBP elevation via activation of sympa-
thetic nervous system (SNS). On the other hand, augmented NKCC1 activity in VSMC of local microcirculatory bed (LMCB) resulted
in suppression of myogenic tonus, elevation of local blood pressure (LBP) that, in turn, contributes to the pathogenesis of renal
insufficiency, heart failure and stroke.
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The data discussed in this review leads to several
conclusions.
First, the transport of monovalent ions across the cells
as well as the regulation of intracellular chloride concen-
tration and of cell volume are major functions of NKCCs. In
renal epithelial cells, reabsorption of salt and osmotically-
obliged water is provided by NKCC2, whereas NKCC1 has a
major impact on [Cl]i, in VSMC and neuronal cells.
Second, in primary hypertension, NKCC1 activity is
increased in VSMC and neurons of PVN leading to elevation
of peripheral resistance in systemic circulation and acti-
vation of SNS, respectively. In both cases, these abnor-
malities are mediated by elevation of [Cl]i and plasma
membrane depolarization.
Third, furosemide and other loop’s diuretics decrease
systemic blood pressure via inhibition of NKCC2 in TAHL and
of NKCC1 in smooth muscles of resistant vessels. However,
the same compounds suppress the myogenic response in
microcirculatory beds of the kidney and the brain thus
increasing the risk of renal and cerebral complications.
In spite of the progress in the understanding the role of
NKCC in the regulation of cellular functions at physiological
and pathophysiological conditions, several questions
remain unanswered. In cultured VSMC as well as in isolated
blood vessels, NKCC1 is activated by phenylephrine,
angiotensin II and other vasoconstrictors and is inhibited by
vasodilators whose action is mediated by cAMP.26,115
Recently, Danielsson and co-workers have reported thatthe combination of Cl-channel blockers and bumetanide
potentiates relaxation of airway smooth muscle rings by
b-adrenergic agonists.140 Hence, the question is whether
NKCC1 contributes to the regulation of vascular tone by
these compounds. A key role of NKCC1 in regulation of
myogenic response of renal afferent arteriole is well-
documented. The question is what is the relative contri-
bution of NKCC1 to the regulation of myogenic response of
microcirculatory beds of the brain and other target-organs
of hypertension.
In vitro experiments have demonstrated that loop’s di-
uretics might be used as a pharmacological tools aug-
menting inhibitory function of GABAA receptors. It was
shown that at least furosemide fluently penetrates human
bloodebrain barrier.141 This finding together with the data
discussed in the previous sections suggests that high-ceiling
diuretics may be used for the regulation of sympathetic
tone via inhibition of NKCC1 in neuronal cells. Indeed, it
was shown that orally administrated furosemide at doses
commonly used in clinic reduced spinal inhibitory inter-
neuronal activity.142 It is important to point out that
currently used high-ceiling diuretics exhibit the same af-
finity for NKCC1 and NKCC2. Because an apparent affinity
for furosemide and bumetanide is proportional to carrier’s
activity,143 inhibition of highly active NKCC2 and diuretic
action of these compounds is much greater than their vas-
odilatory and neuronal effects. It is also important to
mention another side effect of these drugs, i.e., their
prolonged administration may result in the development of
deafness due to inhibition of NKCC1 in epithelial cells of the
NKCC1 and NKCC2 193inner ear.144,145 These issues become important for the
development of novel antihypertensive drugs lacking side-
effects caused by NKCC inhibition in epithelial cells and
myogenic tonus in microcirculatory beds.Conflicts of interest
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